EUVIMEDEUVIMED entdecken
Leserbrief

Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits

Cong Liu, Chengqiang Jin

European Journal of Internal Medicine · 2026-11 · 153 · 107166

DOI: 10.1016/j.ejim.2026.107166 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Internal Medicine, 2026-11. Verfasst von Cong Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging and Laboratory Medicine, Jining Medical University, Jining, 272000, Shandong Province, China. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • School of Medical Imaging and Laboratory Medicine, Jining Medical University, Jining, 272000, Shandong Province, China.
  • Medical Laboratory Department, Affiliated Hospital of Jining Medical University, Jining, 272029, Shandong Province, China. Electronic address: jincq2008@163.com.

Zitieren

APA

Liu, C., & Jin, C. (2026). Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits. European Journal of Internal Medicine, 153, 107166. https://doi.org/10.1016/j.ejim.2026.107166

Vancouver

Liu C, Jin C. Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits. European Journal of Internal Medicine. 2026;153:107166. doi:10.1016/j.ejim.2026.107166

BibTeX
@article{Liu2026,
  author = {Liu, Cong and Jin, Chengqiang},
  title = {Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits},
  journal = {European Journal of Internal Medicine},
  year = {2026},
  volume = {153},
  pages = {107166},
  doi = {10.1016/j.ejim.2026.107166}
}
Kostenlos starten →